US BANCORP \DE\ - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$18,000
+200.0%
4,204
+1101.1%
0.00%
Q1 2021$6,000
-14.3%
3500.0%0.00%
Q4 2020$7,000
+75.0%
350
+23.7%
0.00%
Q3 2020$4,0000.0%2830.0%0.00%
Q2 2020$4,000
-33.3%
283
-43.4%
0.00%
Q1 2020$6,000
+20.0%
500
+150.0%
0.00%
Q4 2019$5,000
+25.0%
2000.0%0.00%
Q3 2019$4,000
-94.7%
200
-95.1%
0.00%
Q2 2019$76,000
+33.3%
4,108
+75.6%
0.00%
Q1 2019$57,000
+5600.0%
2,339
+5604.9%
0.00%
Q4 2016$1,000410.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders